DOTmed.com - Hologic wraps up $3.8 billion Gen-Probe buy
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Philips acquires catheter-based imaging co., Volcano May help Philips break into EURO four billion image-guided therapy market

XR-29's lower dose CT requirements: Will iterative reconstruction play a role? As the industry inches toward new dose requirements, some implementation questions remain

Is Obamacare causing emergency room crowding? No, says new study The Affordable Care Act is not the cause of the problem. It comes from a primary care shortage

Could microwave tomography replace mammography? New experimental technique offers greater specificity with no radiation or patient discomfort

Hitachi partners with iVu for automated whole breast ultrasound

Fetal keepsake ultrasound videos have "potential for harm": FDA expert Time to find a new way to capture memories

Olympus' imaging technology for bladder biopsies gets FDA nod May allow for in-office treatment

Urban health - big cities, big challenges In July, the Carolinas HealthCare System Anson in Wadesboro, N.C., a town of about 5,800 people, opened the doors to its new facility and embarked on a bold experiment.

Breast cancer surgery goes wireless Electromagnetic guidance system for breast cancer treatment gets FDA clearance

Washington state's primary care physician shortage Government applies a Band-Aid

Hologic wraps up $3.8 billion Gen-Probe buy

by Brendon Nafziger , DOTmed News Associate Editor
Hologic said Wednesday that it wrapped up its nearly $3.8 billion cash purchase of molecular diagnostics company Gen-Probe Inc., in line with the company's earlier projections.

On an earnings call this week, the publicly traded women's health medical device company indicated that it expected the deal, first announced in April, to finish by Aug. 1.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



Gen-Probe, based in San Diego, makes tests for STDs and the West Nile Virus, among other conditions.

Gen-Probe's shareholders voted to approve the transaction on Tuesday. Shareholders will receive $82.75 in cash for each share.

Hologic expects the deal to add 20 cents to its adjusted earnings per share for the next fiscal year. The Bedford, Mass.-based company also hopes to realize $75 million in "cost synergies" over the next three years.

This week, while announcing third quarter financial results, Hologic also revealed that it was nearly halfway to its sales goal for its 3-D mammography system, the first of its kind cleared for sale in the United States.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED